The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Epigenetic and genetic features of 24 colon cancer cell lines
Open accessAbstract
Cell lines are invaluable biomedical research tools, and recent literature has emphasized the importance of genotype authentication and characterization. In the present study, 24 out of 27 cell line identities were confirmed by short tandem repeat profiling. The molecular phenotypes of the 24 colon cancer cell lines were examined, and microsatellite instability (MSI) and CpG island methylator phenotype (CIMP) were determined, using the Bethesda panel mononucleotide repeat loci and two epimarker panels, respectively. Furthermore, the BRAF, KRAS and PIK3CA oncogenes were analyzed for mutations in known hotspots, while the entire coding sequences of the PTEN and TP53 tumor suppressors were investigated. Nine cell lines showed MSI. Thirteen and nine cell lines were found to be CIMP positive, using the Issa panel and the Weisenberger et al. panel, respectively. The latter was found to be superior for CIMP classification of colon cancer cell lines. Seventeen cell lines harbored disrupting TP53 mutations. Altogether, 20/24 cell lines had the mitogen-activated protein kinase pathway activating mutually exclusive KRAS or BRAF mutations. PIK3CA and PTEN mutations leading to hyperactivation of the phosphoinositide 3-kinase/AKT pathway were observed in 13/24 cell lines. Interestingly, in four cell lines there were no mutations in neither BRAF, KRAS, PIK3CA nor in PTEN. In conclusion, this study presents molecular features of a large number of colon cancer cell lines to aid the selection of suitable in vitro models for descriptive and functional research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Kumar, P., Henikoff, S., & Ng, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.86 · Cited by 6,521
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
The NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1951 · Cited by 2,620
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278
Cantley, L. C., & Neel, B. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4240 · Cited by 2,006
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Genetic instability in colorectal cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386623a0 · Cited by 1,986
Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion
Dunnen, J. T. D., & Antonarakis, S. E. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1<7::aid-humu4>3.0.co;2-n · Cited by 1,756
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286
CpG island methylator phenotype in cancer
Issa, J.-P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1507 · Cited by 1,098
Classification of human colorectal adenocarcinoma cell lines.
Leibovitz, A., Stinson, J. C., McCombs, W. B., McCoy, C. E., Mazur, K. C., & Mabry, N. D. (1976) · PubMed · Cited by 949
The UCSC Genome Browser database: extensions and updates 2013
Meyer, L. R., Zweig, A. S., Hinrichs, A. S., Karolchik, D., Kuhn, R. M., Wong, M., Sloan, C. A., Rosenbloom, K. R., Roe, G., Rhead, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1048 · Cited by 900
Comparative lesion sequencing provides insights into tumor evolution
Jones, S., Chen, W.-D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Antal, T., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712345105 · Cited by 818
(1975) · Springer eBooks · doi:10.1007/978-1-4757-1647-4 · Cited by 756
Analysis of repetitive element DNA methylation by MethyLight
Weisenberger, D. J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki987 · Cited by 713
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Hinoue, T., Weisenberger, D. J., Lange, C. P. E., Shen, H., Byun, H.-M., Van Den Berg, D., Malik, S., Pan, F., Noushmehr, H., van Dijk, C. M., et al. (2012) · Genome Research · doi:10.1101/gr.117523.110 · Cited by 601
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Shen, L., Toyota, M., Kondo, Y., Lin, E., Zhang, L., Guo, Y., Hernandez, N. S., Chen, X., Ahmed, S., Konishi, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704652104 · Cited by 559
Pruitt, K. D., Harrow, J., Harte, R. A., Wallin, C., Diekhans, M., Maglott, D. R., Searle, S., Farrell, C. M., Loveland, J. E., Ruef, B. J., et al. (2009) · Genome Research · doi:10.1101/gr.080531.108 · Cited by 557
The role of chromosomal instability in tumor initiation
Nowak, M. A., Komarova, N. L., Sengupta, A., Jallepalli, P. V., Shih, I.-M., Vogelstein, B., & Lengauer, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202617399 · Cited by 523
Examining the link between chromosomal instability and aneuploidy in human cells
Thompson, S. L., & Compton, D. A. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200712029 · Cited by 521
Shibata, D., Peinado, M. A., lonov, Y., Malkhosyan, S., & Perucho, M. (1994) · Nature Genetics · doi:10.1038/ng0394-273 · Cited by 484
Chromosomal Instability Confers Intrinsic Multidrug Resistance
Lee, A. J. X., Endesfelder, D., Rowan, A. J., Walther, A., Birkbak, N. J., Futreal, P. A., Downward, J., Szallasi, Z., Tomlinson, I. P. M., Howell, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3604 · Cited by 475
Mutations of GTBP in Genetically Unstable Cells
Papadopoulos, N., Nicolaides, N. C., Liu, B., Parsons, R., Lengauer, C., Palombo, F., D'Arrigo, A., Markowitz, S., Willson, J. K. V., Kinzler, K. W., et al. (1995) · Science · doi:10.1126/science.7604266 · Cited by 468
Chantret, I., Barbat, A., Dussaulx, E., Brattain, M. G., & Zweibaum, A. (1988) · PubMed · Cited by 444
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set
Ikediobi, O. N., Davies, H., Bignell, G., Edkins, S., Stevens, C., O'Meara, S., Santarius, T., Avis, T., Barthorpe, S., Brackenbury, L., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0433 · Cited by 440
The PTEN, Mdm2, p53 tumor suppressor–oncoprotein network
Mayo, L. D., & Donner, D. B. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02166-7 · Cited by 410
Human colonic adenocarcinoma cells: I. Establishment and description of a new line
Tom, B. H., Rutzky, L. P., Jakstys, M. M., Oyasu, R., Kaye, C. I., & Kahan, B. D. (1976) · In Vitro · doi:10.1007/bf02796440 · Cited by 378
Widespread intraspecies cross-contamination of human tumor cell lines arising at source
MacLeod, R. A. F., Dirks, W. G., Matsuo, Y., Kaufmann, M., Milch, H., & Drexler, H. G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<555::aid-ijc19>3.0.co;2-2 · Cited by 364
Ogino, S., Cantor, M., Kawasaki, T., Brahmandam, M., Kirkner, G. J., Weisenberger, D. J., Campan, M., Laird, P. W., Loda, M., & Fuchs, C. S. (2006) · Gut · doi:10.1136/gut.2005.082933 · Cited by 359
Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability
Hermsen, M., Postma, C., Baak, J., Weiss, M., Rapallo, A., Sciutto, A., Roemen, G., Arends, J., Williams, R., Giaretti, W., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.36051 · Cited by 328
Ogino, S., Kawasaki, T., Kirkner, G. J., Loda, M., & Fuchs, C. S. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.060082 · Cited by 294
Genomic and Biological Characterization of Exon 4 KRAS Mutations in Human Cancer
Janakiraman, M., Vakiani, E., Zeng, Z., Pratilas, C. A., Taylor, B. S., Chitale, D., Halilovic, E., Wilson, M., Huberman, K., Ricarte Filho, J. C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0192 · Cited by 290
Dexter, D. L., Barbosa, J. A., & Calabresi, P. (1979) · PubMed · Cited by 266
Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines
Liu, Y., & Bodmer, W. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510146103 · Cited by 257
Quinn, L. A., Moore, G. E., Morgan, R. T., & Woods, L. K. (1979) · PubMed · Cited by 251
Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer.
Eshleman, J. R., Lang, E. Z., Bowerfind, G. K., Parsons, R. E., Vogelstein, B., Willson, J. K. V., Veigl, M. L., Sedwick, W. D., & Markowitz, S. D. (1995) · PubMed · Cited by 242
Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?
van Staveren, W. C. G., Solís, D. Y. W., Hébrant, A., Detours, V., Dumont, J. E., & Maenhaut, C. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.12.004 · Cited by 222
Characteristics of cell lines established from human colorectal carcinoma.
Park, J. G., Oie, H. K., Sugarbaker, P. H., Henslee, J. G., Chen, T. R., Johnson, B. E., & Gazdar, A. F. (1987) · PubMed · Cited by 205
The p53 codon 72 polymorphism and lung cancer risk.
Fan, R., Wu, M., MILLER, D. P., Wain, J. C., Kelsey, K. T., Wiencke, J. K., & Christiani, D. C. (2000) · PubMed · Cited by 205
Langerød, A., Bukholm, I., Bregård, A., Lønning, P. E., Andersen, T. I., Rognum, T. O., Meling, G. I., Lothe, R. A., & Børresen‐Dale, A. (2002) · PubMed · Cited by 204
Self-citationHeterogeneity of human colon carcinoma
Brattain, M. G., Levine, A. E., Chakrabarty, S., Yeoman, L. C., Willson, J. K. V., & Long, B. (1984) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00048384 · Cited by 196
Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines
Gayet, J., Zhou, X.-P., Duval, A., Rolland, S., Hoang, J.-M., Cottu, P., & Hamelin, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204611 · Cited by 186
Heterogeneity of cancer cells from a single human colon carcinoma
Dexter, D. L., Spremulli, E. N., Fligiel, Z., Barbosa, J. A., Vogel, R., VanVoorhees, A., & Calabresi, P. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90312-0 · Cited by 168
ATM activates p53 by regulating MDM2 oligomerization and E3 processivity
Cheng, Q., Chen, L., Li, Z., Lane, W. S., & Chen, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.294 · Cited by 165
Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?
Gazdar, A. F., Gao, B., & Minna, J. D. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.12.005 · Cited by 158
Cicek, M. S., Lindor, N. M., Gallinger, S., Bapat, B. V., Hopper, J. L., Jenkins, M. A., Young, J. P., Buchanan, D. D., Walsh, M. D., Marchand, L. L., et al. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.12.004 · Cited by 148
Wu, Q., Lothe, R. A., Ahlquist, T. C., Silins, I., Trope, C. G., Micci, F., Nesland, J. M., Suo, Z., & Lind, G. E. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-45 · Cited by 148
Self-citationHinoue, T., Weisenberger, D. J., Pan, F., Campan, M., Kim, M.-J., Young, J. P., Whitehall, V., Leggett, B., & Laird, P. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008357 · Cited by 146
Lind, G. E., Danielsen, S. A., Ahlquist, T. C., Merok, M. A., Andresen, K., Skotheim, R. I., Hektoen, M., Rognum, T. O., Meling, G. I., Hoff, G. S., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-85 · Cited by 145
Self-citationBerg, M., Danielsen, S. A., Ahlquist, T. C., Merok, M. A., Ågesen, T. H., Vatn, M. H., Mala, T., Sjo, O. H., Bakka, A. O., Moberg, I. O., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013978 · Cited by 137
Self-citationSääf, A. M., Halbleib, J. M., Chen, X., Yuen, S. T., Leung, S. Y., Nelson, W. J., & Brown, P. O. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-04-0309 · Cited by 135
The CpG island methylator phenotype in colorectal cancer: Progress and problems
Hughes, L., Bakker, C. A. J. K.-D., Smits, K. M., van den Brandt, P. A., Jonkers, D. M. A. E., Ahuja, N., Herman, J. G., Weijenberg, M. P., & van Engeland, M. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.10.005 · Cited by 127
WiDr is a derivative of another colon adenocarcinoma cell line, HT-29
Chen, T. R., Drabkowski, D., Hay, R. J., Macy, M. L., & Peterson, W. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90267-6 · Cited by 115
Frazier, M. L., Xi, L., Zong, J., Viscofsky, N., Rashid, A., Wu, E. F., Lynch, P. M., Amos, C. I., & Issa, J. J. (2003) · PubMed · Cited by 110
Caro, I., Boulenc, X., Rousset, M., Meunier, V., Bourrié, M., Julian, B., Joyeux, H., Roques, C., Berger, Y., Zweibaum, A., et al. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00280-i · Cited by 99
Establishment and characterization of human colorectal cancer cell lines.
McBain, J. A., Weese, J. L., Meisner, L. F., Wolberg, W. H., & Willson, J. K. V. (1984) · PubMed · Cited by 98
Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines
Knutsen, T., Padilla‐Nash, H. M., Wangsa, D., Barenboim‐Stapleton, L., Camps, J., McNeil, N. E., Difilippantonio, M. J., & Ghadimi, Β. M. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20730 · Cited by 82
Bras-Gonçalves, R., Rosty, C., Laurent‐Puig, P., Soulié, P., Dutrillaux, B., & Poupon, M. F. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1019 · Cited by 75
Establishment of a cell line (Co-115) from a human colon carcinoma transplanted into nude mice.
Carrel, S., Sordat, B., & Merenda, C. (1976) · PubMed · Cited by 72
End the scandal of false cell lines
Masters, J. R. (2012) · Nature · doi:10.1038/492186a · Cited by 64
Chen, T. R., Dorotinsky, C., McGuire, L. J., Macy, M. L., & Hay, R. J. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(94)00225-z · Cited by 59
Suardet, L., Gaide, A. C., Calmes, J., Sordat, B., Givel, J. C., Eliason, J. F., & Odartchenko, N. (1992) · PubMed · Cited by 56
Ashraf, S. Q., Nicholls, A. M., Wilding, J. L., Ntouroupi, T. G., Mortensen, N., & Bodmer, W. F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218750110 · Cited by 49
Tibbetts, L. M., Chu, M. Y., Hager, J. C., Dexter, D. L., & Calabresi, P. (1977) · Cancer · doi:10.1002/1097-0142(197711)40:5+<2651::aid-cncr2820400939>3.0.co;2-v · Cited by 44
p53 codon 72 polymorphism and Hematological Cancer Risk: An Update Meta-Analysis
Weng, Y., Lu, L., Yuan, G., Guo, J., Zhang, Z., Xie, X., Chen, G., & Zhang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045820 · Cited by 34
(1981) · PubMed
Cited by
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities.
Hart, T., Chandrashekhar, M., Aregger, M., Steinhart, Z., Brown, K. R., MacLeod, G., Mis, M., Zimmermann, M., Fradet-Turcotte, A., Sun, S., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.015 · Cited by 1,571
Dual proteome-scale networks reveal cell-specific remodeling of the human interactome
Huttlin, E. L., Bruckner, R. J., Navarrete-Perea, J., Cannon, J. R., Baltier, K., Gebreab, F., Gygi, M. P., Thornock, A., Zarraga, G., Tam, S., et al. (2020) · doi:10.1101/2020.01.19.905109 · Cited by 960
M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer
Lan, J., Sun, L., Xu, F., Liu, L., Hu, F., Song, D., Hou, Z., Wu, W., Luo, X., Wang, J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0014 · Cited by 643
Weng, W., Wei, Q., Toden, S., Yoshida, K., Nagasaka, T., Fujiwara, T., Cai, S., Qin, H., Ma, Y., & Goel, A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2541 · Cited by 510
Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies
Berg, K. C. G., Eide, P. W., Eilertsen, I. A., Johannessen, B., Bruun, J., Danielsen, S. A., Bjørnslett, M., Meza-Zepeda, L. A., Eknæs, M., Lind, G. E., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0691-y · Cited by 382
Self-citation
Metadata
- Authors
- Ahmed, D., Eide, P. W., Eilertsen, I. A., Danielsen, S. A., Eknæs, M., Hektoen, M., Lind, G. E., & Lothe, R. A.
- Venue
- Oncogenesis
- Published
- 2013-09-16
- Volume
- 2
- Issue
- 9
- Pages
- e71-e71
- ISSN
- 2157-9024 (ISSN-L)
- OpenAlex
- W2121288523
- Cited by
- 910
- References
- 69
- FWCI
- 29.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.